Global Solid Tumor Drug Market Professional Survey Report 2017

  • KMI-168018
  • Sep 2017
  • 119 pages
  • Pharmaceutical
This report studies Solid Tumor Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
AstraZeneca
Biogen
Baxter
Celgene Corporation
Abbott Laboratories
Pfizer Inc
Amgen Limited & Amgen Ireland Limited
Bristol-Myers Squibb Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Johnson & Johnson

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Small Molecules
Biologics

By Application, the market can be split into
Oncology
Neurology
Radiology
Others

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Solid Tumor Drug Market Professional Survey Report 2017
1 Industry Overview of Solid Tumor Drug
1.1 Definition and Specifications of Solid Tumor Drug
1.1.1 Definition of Solid Tumor Drug
1.1.2 Specifications of Solid Tumor Drug
1.2 Classification of Solid Tumor Drug
1.2.1 Small Molecules
1.2.2 Biologics
1.3 Applications of Solid Tumor Drug
1.3.1 Oncology
1.3.2 Neurology
1.3.3 Radiology
1.3.4 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Solid Tumor Drug
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Solid Tumor Drug
2.3 Manufacturing Process Analysis of Solid Tumor Drug
2.4 Industry Chain Structure of Solid Tumor Drug

3 Technical Data and Manufacturing Plants Analysis of Solid Tumor Drug
3.1 Capacity and Commercial Production Date of Global Solid Tumor Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Solid Tumor Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Solid Tumor Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Solid Tumor Drug Major Manufacturers in 2016

4 Global Solid Tumor Drug Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Solid Tumor Drug Capacity and Growth Rate Analysis
4.2.2 2016 Solid Tumor Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Solid Tumor Drug Sales and Growth Rate Analysis
4.3.2 2016 Solid Tumor Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Solid Tumor Drug Sales Price
4.4.2 2016 Solid Tumor Drug Sales Price Analysis (Company Segment)

5 Solid Tumor Drug Regional Market Analysis
5.1 North America Solid Tumor Drug Market Analysis
5.1.1 North America Solid Tumor Drug Market Overview
5.1.2 North America 2012-2017E Solid Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Solid Tumor Drug Sales Price Analysis
5.1.4 North America 2016 Solid Tumor Drug Market Share Analysis
5.2 China Solid Tumor Drug Market Analysis
5.2.1 China Solid Tumor Drug Market Overview
5.2.2 China 2012-2017E Solid Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Solid Tumor Drug Sales Price Analysis
5.2.4 China 2016 Solid Tumor Drug Market Share Analysis
5.3 Europe Solid Tumor Drug Market Analysis
5.3.1 Europe Solid Tumor Drug Market Overview
5.3.2 Europe 2012-2017E Solid Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Solid Tumor Drug Sales Price Analysis
5.3.4 Europe 2016 Solid Tumor Drug Market Share Analysis
5.4 Southeast Asia Solid Tumor Drug Market Analysis
5.4.1 Southeast Asia Solid Tumor Drug Market Overview
5.4.2 Southeast Asia 2012-2017E Solid Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Solid Tumor Drug Sales Price Analysis
5.4.4 Southeast Asia 2016 Solid Tumor Drug Market Share Analysis
5.5 Japan Solid Tumor Drug Market Analysis
5.5.1 Japan Solid Tumor Drug Market Overview
5.5.2 Japan 2012-2017E Solid Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Solid Tumor Drug Sales Price Analysis
5.5.4 Japan 2016 Solid Tumor Drug Market Share Analysis
5.6 India Solid Tumor Drug Market Analysis
5.6.1 India Solid Tumor Drug Market Overview
5.6.2 India 2012-2017E Solid Tumor Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Solid Tumor Drug Sales Price Analysis
5.6.4 India 2016 Solid Tumor Drug Market Share Analysis

6 Global 2012-2017E Solid Tumor Drug Segment Market Analysis (by Type)
6.1 Global 2012-2017E Solid Tumor Drug Sales by Type
6.2 Different Types of Solid Tumor Drug Product Interview Price Analysis
6.3 Different Types of Solid Tumor Drug Product Driving Factors Analysis
6.3.1 Small Molecules of Solid Tumor Drug Growth Driving Factor Analysis
6.3.2 Biologics of Solid Tumor Drug Growth Driving Factor Analysis

7 Global 2012-2017E Solid Tumor Drug Segment Market Analysis (by Application)
7.1 Global 2012-2017E Solid Tumor Drug Consumption by Application
7.2 Different Application of Solid Tumor Drug Product Interview Price Analysis
7.3 Different Application of Solid Tumor Drug Product Driving Factors Analysis
7.3.1 Oncology of Solid Tumor Drug Growth Driving Factor Analysis
7.3.2 Neurology of Solid Tumor Drug Growth Driving Factor Analysis
7.3.3 Radiology of Solid Tumor Drug Growth Driving Factor Analysis
7.3.4 Others of Solid Tumor Drug Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Solid Tumor Drug
8.1 AstraZeneca
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 AstraZeneca 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 AstraZeneca 2016 Solid Tumor Drug Business Region Distribution Analysis
8.2 Biogen
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Biogen 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Biogen 2016 Solid Tumor Drug Business Region Distribution Analysis
8.3 Baxter
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Baxter 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Baxter 2016 Solid Tumor Drug Business Region Distribution Analysis
8.4 Celgene Corporation
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Celgene Corporation 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Celgene Corporation 2016 Solid Tumor Drug Business Region Distribution Analysis
8.5 Abbott Laboratories
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Abbott Laboratories 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Abbott Laboratories 2016 Solid Tumor Drug Business Region Distribution Analysis
8.6 Pfizer Inc
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Pfizer Inc 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Pfizer Inc 2016 Solid Tumor Drug Business Region Distribution Analysis
8.7 Amgen Limited & Amgen Ireland Limited
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Amgen Limited & Amgen Ireland Limited 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Amgen Limited & Amgen Ireland Limited 2016 Solid Tumor Drug Business Region Distribution Analysis
8.8 Bristol-Myers Squibb Company
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Bristol-Myers Squibb Company 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Bristol-Myers Squibb Company 2016 Solid Tumor Drug Business Region Distribution Analysis
8.9 GlaxoSmithKline plc.
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 GlaxoSmithKline plc. 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 GlaxoSmithKline plc. 2016 Solid Tumor Drug Business Region Distribution Analysis
8.10 F. Hoffmann-La Roche Ltd.
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 F. Hoffmann-La Roche Ltd. 2016 Solid Tumor Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 F. Hoffmann-La Roche Ltd. 2016 Solid Tumor Drug Business Region Distribution Analysis
8.11 Eli Lilly and Company
8.12 Johnson & Johnson

9 Development Trend of Analysis of Solid Tumor Drug Market
9.1 Global Solid Tumor Drug Market Trend Analysis
9.1.1 Global 2017-2022 Solid Tumor Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Solid Tumor Drug Sales Price Forecast
9.2 Solid Tumor Drug Regional Market Trend
9.2.1 North America 2017-2022 Solid Tumor Drug Consumption Forecast
9.2.2 China 2017-2022 Solid Tumor Drug Consumption Forecast
9.2.3 Europe 2017-2022 Solid Tumor Drug Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Solid Tumor Drug Consumption Forecast
9.2.5 Japan 2017-2022 Solid Tumor Drug Consumption Forecast
9.2.6 India 2017-2022 Solid Tumor Drug Consumption Forecast
9.3 Solid Tumor Drug Market Trend (Product Type)
9.4 Solid Tumor Drug Market Trend (Application)

10 Solid Tumor Drug Marketing Type Analysis
10.1 Solid Tumor Drug Regional Marketing Type Analysis
10.2 Solid Tumor Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Solid Tumor Drug by Region
10.4 Solid Tumor Drug Supply Chain Analysis

11 Consumers Analysis of Solid Tumor Drug
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
?

12 Conclusion of the Global Solid Tumor Drug Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source


Purchase this Market Research Report



Contact Us


Mannan
Mannan Shaikh
Head-Sales
mansing
Mansingh Surve
Manager-Sales
Vivek
Vivek Pandey
Assistant Manager-Sales
Roshnee
Roshnee Tendulkar
Team Lead-Sales
view